// App-Quantinova.ai

20 : Oral Rivaroxaban for the Treatment of Symptomatic Venous Thromboembolism: A Pooled Analysis of the EINSTEIN DVT and EINSTEIN PE Studies

Researchers

Presenter

  • Harry Roger Buller

Principal Investigators

  • N/A

Medical Centers

  • Pulmonary Medicine, Academic Medical Centre, Amsterdam, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

  • Renal insufficiency

Biomarkers

  • Creatinine

Drug/Treatment

  • rivaroxaban

  • Enoxaparin

  • Enoxaparin sodium

  • Warfarin

Outcome

  • N/A

Study Design

  • open label

  • randomized

  • non inferiority

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved